MedPath

A Comparative study of different treatment regimes for brain tuberculosis

Phase 1
Conditions
Health Condition 1: A171- Meningeal tuberculoma
Registration Number
CTRI/2019/05/019222
Lead Sponsor
Department of Science and Technology
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Open to Recruitment
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

Clinically and radiologically suspected cases of CNS tuberculoma

Exclusion Criteria

<18yrs, pregnant, HIV positive,refusal to participate in the study

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Reduction in size/disappearance of TuberculomaTimepoint: 3 months, 6 months, 12 months, 18 months
Secondary Outcome Measures
NameTimeMethod
Improvement in clinical parameters,symptoms and signs like headache,focal deficits and reduction in disability scores. <br/ ><br>Timepoint: 3 months, 6 months, 12 months, 18 months
© Copyright 2025. All Rights Reserved by MedPath